BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1463693)

  • 1. A case of lung carcinoma induced by radioactive iodine given for disseminated thyroid carcinoma.
    Laing RW; Saunders MI
    Clin Oncol (R Coll Radiol); 1992 Nov; 4(6):394-5. PubMed ID: 1463693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: An institutional experience and review of the literature.
    Gow KW; Lensing S; Hill DA; Krasin MJ; McCarville MB; Rai SN; Zacher M; Spunt SL; Strickland DK; Hudson MM
    J Pediatr Surg; 2003 Nov; 38(11):1574-80. PubMed ID: 14614703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Promising radioiodine therapy of pulmonary metastases of a papillary carcinoma of the thyroid in a 12-year-old boy].
    Blattmann H; Beck A; Moser E
    Radiologe; 1992 Feb; 32(2):68-72. PubMed ID: 1565783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine.
    Pavithran K; Doval DC
    Am J Clin Oncol; 2005 Apr; 28(2):216. PubMed ID: 15803020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
    Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
    Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary fibrosis following radioiodine therapy of pulmonary metastases from differentiated thyroid carcinoma.
    Chen L; Shen Y; Luo Q; Yu Y; Lu H; Zhu R
    Thyroid; 2010 Mar; 20(3):337-40. PubMed ID: 20187786
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of chronic myelogenous leukemia following I131 therapy for metastatic thyroid carcinoma.
    Torng JK; Chen YC; Liu CH; Chen FW
    Taiwan Yi Xue Hui Za Zhi; 1984 Jul; 83(7):730-5. PubMed ID: 6594437
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience.
    Brown AP; Greening WP; McCready VR; Shaw HJ; Harmer CL
    Br J Radiol; 1984 Apr; 57(676):323-7. PubMed ID: 6704664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radioiodide therapy in pulmonary metastasis of differentiated thyroid cancer--factors affecting the success of I-131 therapy].
    Takada Y; Ohta Y; Kawasaki S; Maki M; Hiroe M; Kusakabe K; Shigeta A; Yamazaki T; Fujimoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jul; 47(7):962-70. PubMed ID: 3658666
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
    Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
    J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma.
    Bhattacharyya N; Chien W
    Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):607-10. PubMed ID: 16944659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of radioiodine therapy in patients with pulmonary metastases of differentiated thyroid cancer].
    Ono Y; Yamamoto Y; Nishiyama Y; Nakano S; Takahashi K; Kawasaki Y; Satoh K; Ohkawa M; Tanabe M
    Kaku Igaku; 2000 Nov; 37(6):661-70. PubMed ID: 11193452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma.
    Corrêa NL; de Sá LV; de Mello RC
    Thyroid; 2017 Feb; 27(2):261-270. PubMed ID: 27762670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments.
    Leger AF; Pellan M; Dagousset F; Chevalier A; Keller I; Clerc J
    Br J Radiol; 2005 May; 78(929):428-32. PubMed ID: 15845937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.
    Lin JD; Kao PF; Chao TC
    Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of radioactive iodine in thyroid carcinoma.
    Goolden AW
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):339-43. PubMed ID: 3281849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer.
    Kinuya S; Yokoyama K; Michigishi T; Tonami N
    Ann Nucl Med; 2006 Aug; 20(7):499-502. PubMed ID: 17037283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary squamous cell carcinoma of the thyroid years after radioactive iodine treatment.
    Yucel H; Schaper NC; van Beek M; Bravenboer B
    Neth J Med; 2010 May; 68(5):224-6. PubMed ID: 20508272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary metastases in children and adolescents with papillary thyroid cancer in China: prognostic factors and outcomes from treatment with
    Zhang XY; Song HJ; Qiu ZL; Shen CT; Chen XY; Sun ZK; Wei WJ; Zhang GQ; Luo QY
    Endocrine; 2018 Oct; 62(1):149-158. PubMed ID: 30022382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An aggressive radio-resistant papillary thyroid cancer.
    Mehta RS; Negin B; Popii V; Langer C
    Clin Adv Hematol Oncol; 2008 Oct; 6(10):761-7. PubMed ID: 18997667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.